Calendar AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Market Closed - Nasdaq 04:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
78.18 USD -0.79% Intraday chart for AstraZeneca PLC +1.48% +16.08%

Chart calendar AstraZeneca PLC

150aa52da3846a05ee3.EsjR2ep_jbFv-U0zfykIQ7DObLzAFqVXicDaj9ePeqY.fIafvJ496sI7iyBGS2FbJtOfPYu6I-YP55SIxJOiO9R0jZWr3Sb8wwbUJg~20daefe9a5b1303065454d3192c26278

Upcoming events on AstraZeneca PLC

2024-06-03 08:30 pm Investor Meeting
2024-07-25 02:00 am Q2 2024 Earnings Release
2024-11-12 02:00 am Q3 2024 Earnings Release
2025-02-05 Q4 2024 Earnings Release (Projected)
2025-04-24 Q1 2025 Earnings Release (Projected)
2025-07-23 Q2 2025 Earnings Release (Projected)
2025-11-05 Q3 2025 Earnings Release (Projected)

Past events on AstraZeneca PLC

2024-05-21 05:15 pm American Thoracic Society Conference - Abstarct Number - 314
2024-05-21 05:15 pm American Thoracic Society Conference - Abstarct Number - 302
2024-05-21 05:15 pm American Thoracic Society Conference - Ritchie AI
2024-05-21 02:30 pm American Thoracic Society Conference - Abstarct Number - P628
2024-05-21 02:30 pm American Thoracic Society Conference - Abstarct Number - P604
2024-05-21 02:30 pm American Thoracic Society Conference - Abstarct Number - P616
2024-05-21 02:30 pm American Thoracic Society Conference - Abstarct Number - P655
2024-05-21 02:30 pm American Thoracic Society Conference - Abstarct Number - P638
2024-05-21 12:15 pm American Thoracic Society Conference - Abstarct Number - P595
2024-05-21 12:15 pm American Thoracic Society Conference - Abstarct Number - P646
2024-05-21 05:00 am Investor Day
2024-05-20 02:30 pm American Thoracic Society Conference - Abstarct Number - P626
2024-05-20 12:15 pm American Thoracic Society Conference - Abstarct Number - P594
2024-05-20 12:15 pm American Thoracic Society Conference - Singh D
2024-05-19 05:15 pm American Thoracic Society Conference - Abstarct Number - 705
2024-05-19 02:30 pm American Thoracic Society Conference - Abstarct Number - P192
2024-05-19 02:30 pm American Thoracic Society Conference - Abstarct Number - P159
2024-05-19 02:30 pm American Thoracic Society Conference - Abstarct Number - P406
2024-05-19 12:15 pm American Thoracic Society Conference - Abstarct Number - P297
2024-05-19 12:15 pm American Thoracic Society Conference - Abstarct Number - 913

Past dividends on AstraZeneca PLC

2024-02-21 Final Payment 1.56 GBP
2023-08-09 Interim Payment 0.718 GBP
2023-02-22 Final Payment 1.628 GBP
2022-08-10 Interim Payment 0.764 GBP
2022-02-23 Final Payment 1.453 GBP
2021-08-11 Interim Payment 0.648 GBP
2021-02-24 Final Payment 1.374 GBP
2020-08-12 Interim Payment 0.696 GBP
2020-02-26 Final Payment 1.464 GBP
2019-08-07 Interim Payment 0.719 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
24 384
24 440
-0.23%
26 617
26 378
0.91%
37 417
36 239
3.25%
44 351
44 465
-0.26%
45 811
45 716
0.21%

51 623

EBITDA
Million USD
Released
Forecast
Spread
6 686
6 882
-2.84%
8 311
8 087
2.76%
7 586
10 816
-29.87%
9 237
13 681
-32.49%
13 580
15 477
-12.26%

17 668

EBIT
Million USD
Released
Forecast
Spread
6 436
6 631
-2.95%
7 340
7 417
-1.04%
9 928
10 003
-0.75%
13 350
13 702
-2.57%
14 534
15 036
-3.34%

16 861

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 548
2 130
-27.34%
3 916
4 387
-10.74%
-265
1 510
-117.55%
2 501
3 511
-28.78%
6 899
9 269
-25.57%

10 901

Net income
Million USD
Released
Forecast
Spread
1 335
1 895
-29.55%
3 196
2 930
9.09%
112
2 055
-94.55%
3 288
4 262
-22.86%
5 961
6 597
-9.64%

8 881

EPS
USD
Released
Forecast
Spread
1,03
1,41
-26.77%
2,44
2,50
-2.26%
0,08
1,99
-95.98%
2,11
2,81
-24.96%
3,81
4,34
-12.22%

5,69

Announcement Date14/02/2011/02/2110/02/2209/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
11 390
10 967
3.86%
10 771
10 577
1.83%
10 982
10 848
1.23%
11 207
11 287
-0.71%
10 879
10 559
3.03%
11 416
11 018
3.62%
11 492
11 529
-0.32%
12 024
12 007
0.14%
12 679
11 812
7.34%

12 673


12 887


13 491


13 530


13 805

EBITDA
Million USD
Released
Forecast
Spread
2 187
3 894
-43.83%
1 896
5 337
-64.47%
2 579
2 556
0.88%
2 574
2 966
-13.22%



3 732
4 074
-8.39%










4 396


4 404


5 260







EBIT
Million USD
Released
Forecast
Spread
3 961
3 486
13.62%
3 365
3 291
2.25%
3 413
3 189
7.03%
2 610
2 916
-10.5%
3 946
3 517
12.21%
4 291
4 005
7.13%
3 545
3 537
0.24%
2 752
3 206
-14.15%
4 310
3 911
10.2%

4 170


4 244


4 008







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
553
972
-43.08%
247
580
-57.38%
922
1 007
-8.4%
778
806
-3.47%
2 262
1 834
23.34%
2 088
2 410
-13.36%
1 652
2 510
-34.17%
897
1 671
-46.32%
2 800
2 296
21.95%

2 361


2 740


3 099







Net income
Million USD
Released
Forecast
Spread
386
1 086
-64.45%
360
946
-61.96%
1 640
895
83.16%
901
2 096
-57.02%
1 803
1 594
13.14%
1 818
2 123
-14.37%
1 378
1 705
-19.16%
959
2 313
-58.53%
2 179
2 065
5.52%

2 362


2 279


2 501







EPS
USD
Released
Forecast
Spread
0,25
0,70
-64.25%
0,23
0,78
-70.61%
1,05
0,58
82.48%
0,58
1,35
-57.11%
1,16
1,08
7.44%
1,17
1,36
-14.03%
0,89
1,09
-18.64%
0,62
1,49
-58.3%
1,41
1,33
6.28%

1,51


1,46


1,61







Announcement Date29/04/2229/07/2210/11/2209/02/2327/04/2328/07/2309/11/2308/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise